Holmium:YAG laser prostatectomy: results of U.S. pilot study.

The holmium:YAG (Ho:YAG) laser wavelength's ability to vaporize and incise soft tissue offers potential advantages for prostatectomy compared with the Nd:YAG laser, which primarily produces tissue coagulation. In this initial U.S. trial, Ho:YAG laser prostatectomy was performed in 20 men, including 2 men treated immediately prior to radical prostatectomy to assess Ho:YAG laser tissue effects in the prostate. A total of 18 men were treated for clinically symptomatic bladder outlet obstruction secondary to benign prostatic hyperplasia (BPH). Estimated excess BPH tissue averaged 24 g (range 5-50 g). A mean of 129 kJ of Ho:YAG laser energy was delivered, combined with a mean of 11 kJ of Nd:YAG energy to provide supplemental coagulation for hemostasis. The mean operative time was 1 hour 34 minutes. No significant intraoperative changes in hematocrit or serum electrolytes were documented. No perioperative or late complications occurred. The mean postoperative catheterization time was 1.4 days. Of the 18 patients, 16 (90%) underwent a successful voiding trial on the first postoperative morning. Immediate improvement in voiding, comparable to that seen after transurethral electrocautery resection of the prostate (TURP), was reported by all patients. Ho:YAG laser resection of the prostate appears to be a useful surgical technique associated with minimal morbidity and immediate improvement in voiding.

[1]  J. Kabalin,et al.  Insight into mechanism of neodymium: yttrium-aluminum-garnet laser prostatectomy utilizing the high-power contact-free beam technique. , 1995, Urology.

[2]  C. Fowler,et al.  A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. , 1995, Urology.

[3]  A. Costello,et al.  Further evaluation of transurethral laser ablation of the prostate in patients treated with anticoagulant therapy. , 1995, The Australian and New Zealand journal of surgery.

[4]  R. Dmochowski,et al.  Outpatient visual laser-assisted prostatectomy under local anesthesia. , 1994, Urology.

[5]  J. Kabalin,et al.  Characterization of tissue effects produced by the Prolase II lateral‐firing neodymm:YAG laser fiber in the canine prostate , 1994, Lasers in surgery and medicine.

[6]  J. Kabalin,et al.  Dosimetry studies utilizing the urolase right angle firing neodymium: YAG laser fiber , 1994, Lasers in surgery and medicine.

[7]  J. Kabalin,et al.  Urolase laser prostatectomy in patients on warfarin anticoagulation: a safe treatment alternative for bladder outlet obstruction. , 1993, Urology.

[8]  P. Gilling,et al.  Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. , 1996, Urology.

[9]  J. Kabalin,et al.  Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. , 1995, The Journal of urology.

[10]  A. Costello,et al.  Laser ablation of the prostate in patients with benign prostatic hypertrophy. , 1992, British journal of urology.

[11]  R. Price,et al.  Pathologic changes occurring in the prostate following transurethral laser prostatectomy , 1992, Lasers in surgery and medicine.

[12]  L. W. Rodgers,et al.  Depth of penetration of the neodymium:yttrium-aluminum-garnet laser in the human prostate at various dosimetry. , 1994, Urology.

[13]  J. Kabalin,et al.  Holmium:YAG laser prostatectomy canine feasibility study , 1996, Lasers in surgery and medicine.

[14]  P. Rosier,et al.  Urodynamic results of laser treatment in patients with benign prostatic hyperplasia. Can outlet obstruction be relieved? , 1995, The Journal of urology.

[15]  John N. Kabalin,et al.  Neodymium: YAG Laser Coagulation Prostatectomy , 1996 .

[16]  B Stein,et al.  A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. , 1995, Urology.

[17]  J. Kabalin,et al.  Neodymium: yttrium-aluminum-garnet laser dosimetry for the prolase II side-firing delivery system in the human prostate. , 1995, Urology.

[18]  J P Norris,et al.  Visual laser ablation of the prostate: clinical experience in 108 patients. , 1993, The Journal of urology.

[19]  M. Terris,et al.  Dosimetry studies utilizing the urolase right‐angle firing Neodymium: YAG laser fiber in the human prostate , 1996, Lasers in surgery and medicine.